AtaiBeckley Announces Positive Phase 2a Results for BPL-003 in Treatment-Resistant Depression with FDA Breakthrough Therapy Designation April 27, 2026 depression . Originally reported by Quiver Quantitative. Read more Source: https://www.quiverquant.com/news/AtaiBeckley+Announces+Positive+Phase+2a+Results+for+BPL-003+in+Treatment-Resistant+Depression+with+FDA+Breakthrough+Therapy+Designation
